Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
2.040
+0.070 (3.55%)
At close: Sep 8, 2026, 4:00 PM EDT
2.000
-0.040 (-1.96%)
After-hours: Sep 8, 2026, 8:00 PM EDT
Regentis Biomaterials Market Cap
Regentis Biomaterials has a market cap or net worth of $10.57 million as of September 8, 2026.
Market Cap
10.57M
Enterprise Value
4.38M
1-Year Change
n/a
Ranking
Category
Stock Price
$2.04
ChartMarket Cap Chart
Since the IPO on December 4, 2025, Regentis Biomaterials's market cap has decreased from $39.44M to $10.57M, a decrease of -73.21%. That is a compound annual growth rate of -82.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 10.57M | -69.73% |
| Dec 31, 2025 | 34.91M | -11.48% |
| Dec 4, 2025 | 39.44M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Daxor | 61.07M |
| Precision Optics Corporation | 47.99M |
| Nephros | 47.35M |
| Milestone Scientific | 39.05M |
| Harvard Bioscience | 36.19M |
| Femasys | 22.45M |
| Retractable Technologies | 20.96M |
| Bionano Genomics | 14.13M |